Holen Sie sich die Stockscreener-App
1.66
2.35%
-0.04
Handel nachbörslich:
1.64
-0.02
-1.20%
Okyo Pharma Limited Aktie (OKYO) Neueste Nachrichten
OKYO Pharma prices public offering at $1.85/share to raise up to $20M - MSN
OKYO Pharma Raises About $22 Million After Underwriter Partially Exercises Share Option - TipRanks
Market Wrap: Is OKYO Pharma Limited a turnaround story2026 Momentum Check & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Geopolitics Watch: Will Coeptis Therapeutics Holdings Inc. Equity Warrant benefit from rate cutsQuarterly Portfolio Report & AI Based Trade Execution Alerts - baoquankhu1.vn
Published on: 2026-03-07 08:54:47 - baoquankhu1.vn
Setup Watch: Can OKYO Pharma Limited maintain sales growthQuarterly Profit Review & Growth Focused Entry Point Reports - baoquankhu1.vn
Market Rankings: Is OKYO Pharma Limited stock trending bullishIndex Update & Capital Protection Trade Alerts - baoquankhu1.vn
OKYO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
OKYO Pharma to present first-in-human urcosimod data at ARVO 2026 - Proactive Investors
OKYO Pharma’s Urcosimod NCP Data Selected for Presentation at ARVO 2026 - TipRanks
OKYO Pharma's Urcosimod Selected for Presentation at ARVO 2026 Annual Meeting Following Positive Phase 2a Trial Results for Neuropathic Corneal Pain Treatment - Quiver Quantitative
OKYO (Nasdaq: OKYO) to present Fast Track NCP therapy data at ARVO 2026 - Stock Titan
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress - GlobeNewswire
Analysts Set OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Target Price at $6.00 - Defense World
Piper Sandler Initiates Coverage on OKYO Pharma (NASDAQ:OKYO) - Defense World
OKYO Pharma (NASDAQ:OKYO) Raised to "Strong-Buy" at Piper Sandler - MarketBeat
Piper Sandler initiates OKYO Pharma stock with Overweight rating By Investing.com - Investing.com Nigeria
How OKYO Pharma Limited stock compares to industry benchmarksWeekly Trade Review & Daily Volume Surge Signals - mfd.ru
CEO Moves: Is OKYO Pharma Limited a turnaround story2025 Pullback Review & Weekly High Return Stock Forecasts - baoquankhu1.vn
How interest rate cuts could boost OKYO Pharma Limited stockJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - mfd.ru
Piper Sandler initiates OKYO Pharma stock with Overweight rating - Investing.com South Africa
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Piper Sandler Initiates Coverage on OKYO Pharma With Overweight Rating, $7 Price Target - marketscreener.com
Big Money Moves: How interest rate cuts could boost OKYO Pharma Limited stock2025 Investor Takeaways & Entry and Exit Point Strategies - mfd.ru
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares - VisionMonday.com
Small cap wrap: Trust Stamp, HIVE Digital Technologies, OKYO Pharma... - Proactive financial news
OKYO Pharma has analysts bullish as FDA endorses Phase 2b/3 trial in neuropathic corneal pain - Proactive financial news
What risks investors should watch in OKYO Pharma Limited stock2025 Market Sentiment & Technical Entry and Exit Alerts - mfd.ru
Options Flow: Is OKYO Pharma Limited exposed to political riskQuarterly Investment Review & Safe Capital Allocation Plans - baoquankhu1.vn
Income Plays: Is Amylyx Pharmaceuticals Inc in accumulation or distribution phaseJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Support Test: Is APWC a strong candidate for buy and holdJuly 2025 Review & Expert Curated Trade Setups - baoquankhu1.vn
Can OKYO Pharma Limited stock deliver sustainable ROEPortfolio Performance Report & Growth Focused Stock Reports - mfd.ru
OKYO Pharma Prices Public Offering at $1.85 per Share - Intellectia AI
OKYO PE Ratio & Valuation, Is OKYO Overvalued - Intellectia AI
Is OKYO Pharma Limited a turnaround storyWeekly Stock Analysis & Reliable Price Breakout Signals - mfd.ru
Small cap wrap: OKYO Pharma, HIVE Digital Technologies, Synchronoss Technologies... - Proactive financial news
Published on: 2026-02-14 12:01:38 - baoquankhu1.vn
OKYO Pharma Limited Sponsored ADR (NASDAQ:OKYO) Sees Significant Increase in Short Interest - MarketBeat
OKYO Pharma launches underwritten public offering of ordinary shares - MSN
OKYO Pharma announces $20 million public offering of ordinary shares - Investing.com South Africa
OKYO Pharma announces $20 million public offering of ordinary shares By Investing.com - Investing.com Canada
OKYO Pharma Prices $20 Million Underwritten Share Offering to Fund Clinical Development - TipRanks
OKYO Pharma stock tumbles on $20 million public offering announcement - Investing.com South Africa
OKYO Pharma stock tumbles on $20 million public offering announcement By Investing.com - Investing.com Canada
OKYO Pharma prices $20M offering to fund late-stage eye drug trial - Yahoo Finance
OKYO Pharma Prices $20 Million Public Share Offering to Fund Eye Disease Pipeline - TipRanks
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):